| Regorafenib studied in …STUDIED_INderived200 of 244show all (up to 200) |
|---|
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · 244 trials list this drug (57 active) | — | — | Melanoma,Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06246643Phase 2 · active not recruiting A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05672316Phase 1/Phase 2 · active not recruiting Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy · 244 trials list this drug (57 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm,Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04787341Phase 2 · completed PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07071961Phase 2 · recruiting Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial] · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07730489Phase 3 · not yet recruiting A Study Comparing BL-M07D1 With Physician's Choice Therapy in Patients With HER2 IHC3+ Advanced Colorectal Cancer Who Failed Prior Treatment With Oxaliplatin, Fluorouracil and Irinotecan · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05328908Phase 3 · terminated A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Later-lines of Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05395741Phase 1/Phase 2 · completed Regorafenib in Patients With Refractory Primary Bone Tumors · 244 trials list this drug (57 active) | — | — | Osteosarcoma,Bone Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06820957Phase 2/Phase 3 · active not recruiting Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body · 244 trials list this drug (57 active) | — | — | Ewing Sarcoma,High Grade Sarcoma,Round Cell Sarcoma with EWSR1-non-ETS Fusion+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02955940Phase 2 · active not recruiting An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib · 244 trials list this drug (57 active) | — | — | Malignant Breast Neoplasm,Malignant Lung Neoplasm,Malignant Pancreatic Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02657551Phase 2 · completed A Study Using Regorafenib as Second or Third Line Therapy in Metastatic Medullary Thyroid Cancer · 244 trials list this drug (57 active) | — | — | Malignant Thyroid Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03844620Phase 2 · active not recruiting Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07750041Phase 1/Phase 2 · not yet recruiting A Phase Ib/II Study of SYS6090 Combination Therapy in Advanced Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03970447Phase 2/Phase 3 · recruiting A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma · 244 trials list this drug (57 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05198934Phase 3 · completed Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02389244Phase 2 · completed A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas · 244 trials list this drug (57 active) | — | — | Chondrosarcoma,Ewing Sarcoma,Osteosarcoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05194293Phase 2 · active not recruiting Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05425940Phase 3 · active not recruiting Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06087263Phase 2 · active not recruiting Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting. · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04116541Phase 2 · recruiting A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors. · 244 trials list this drug (57 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03657641Phase 1/Phase 2 · active not recruiting Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06902246Phase 2 · withdrawn Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04879368Phase 3 · completed RegoNivo vs Standard of Care Chemotherapy in AGOC · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07379047Phase 2/Phase 3 · recruiting Efficacy and Safety of NB003 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07567222Phase 1 · recruiting Clinical Study of Novel Therapeutic Vaccine for Advanced Solid Tumors · 244 trials list this drug (57 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07495579Phase 2 · not yet recruiting Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE) · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05064059Phase 3 · completed A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007) · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04503694Phase 2 · active not recruiting Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06275919Phase 2 · recruiting Regorafenib for Recurrent Meningioma (MIRAGE Trial) · 244 trials list this drug (57 active) | — | — | Grade 3 Meningioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07328009Phase 2 · recruiting A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07537985NA · completed Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514429Phase 2 · not yet recruiting Regorafenib After Failure of Lenvatinib in Patients With Unresectable HCC: The RELEVANT-HCC Trial · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514455Phase 2 · not yet recruiting Regorafenib After Treatment Failure of First Line Immune Checkpoint Inhibitor Treatment in Advanced Hepatocellular Carcinoma Patients · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793361Phase 2 · completed Phase II Study of Regorafenib as Maintenance Therapy · 244 trials list this drug (57 active) | — | — | Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01900743Phase 2 · completed Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma · 244 trials list this drug (57 active) | — | — | Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02310477completed Regorafenib in Metastatic Colorectal Cancer : a Cohort Study in the Real-life Setting · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02386397Phase 1/Phase 2 · completed Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer · 244 trials list this drug (57 active) | — | — | Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07137390Phase 1/Phase 2 · withdrawn A Trial of Regorafenib Plus Lorigerlimab as Neoadjuvant Therapy for Patients With pMMR/MSS, Resectable, Lung-limited Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04327700Phase 2 · terminated Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04757363Phase 2 · active not recruiting A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer · 244 trials list this drug (57 active) | — | — | Esophageal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06137170completed A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07223567Phase 2 · withdrawn A Trial of Regorafenib Plus Lorigerlimab in Patients With Locally Recurrent or Regrowing pMMR/MSS Localized Rectal Cancer · 244 trials list this drug (57 active) | — | — | Rectal Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03712943Phase 1 · completed Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05644379Phase 1 · active not recruiting A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Advanced Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392866Phase 2/Phase 3 · not yet recruiting A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04776148Phase 3 · completed Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017) · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04362839Phase 1 · completed Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Adenocarcinoma,Colorectal Carcinoma,Malignant Colorectal Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04781192Phase 1/Phase 2 · active not recruiting The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers · 244 trials list this drug (57 active) | — | — | Malignant Biliary Tract Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05155189Phase 1 · recruiting A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03994601Phase 1/Phase 2 · completed An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers · 244 trials list this drug (57 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06006923Phase 2 · terminated Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal Cancer · 244 trials list this drug (57 active) | — | — | MSI-H Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06095375Phase 1 · completed Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients · 244 trials list this drug (57 active) | — | — | Glioblastoma, IDH-Wildtype,MGMT-Methylated Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03042689Phase 1 · completed Study of Regorafenib in Patients With Advanced Myeloid Malignancies · 244 trials list this drug (57 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06283134Phase 1 · not yet recruiting A Clinical Study of BioTTT001 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05830084Phase 1 · active not recruiting Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma · 244 trials list this drug (57 active) | — | — | Ewing Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07300488Phase 2/Phase 3 · active not recruiting Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07310173Phase 2 · recruiting Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213570Phase 2 · recruiting STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03377361Phase 1/Phase 2 · completed An Investigational Immuno-therapy Study Of Nivolumab In Combination With Trametinib With Or Without Ipilimumab In Participants With Previously Treated Cancer of the Colon or Rectum That Has Spread · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm,Colorectal Carcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05600309Phase 3 · completed A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03829462Phase 3 · active not recruiting Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06454409Phase 1 · suspended Regorafenib in Combination With Venetoclax and Azacitidine for the Treatment of Patients With Relapsed or Refractory Acute Myeloid Leukemia · 244 trials list this drug (57 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Myelodysplastic Syndrome/Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05839951completed An Observational Study Called STAR-T to Learn More About the Sequential Treatment With Regorafenib and TAS-102 in Adults With Metastatic Colorectal Cancer Under Real World Conditions · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04803877Phase 2 · active not recruiting SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma · 244 trials list this drug (57 active) | — | — | Osteosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04660812Phase 1/Phase 2 · completed An Open Label Study Evaluating the Efficacy and Safety of Etrumadenant (AB928) Based Treatment Combinations in Participants With Metastatic Colorectal Cancer. · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02098538Phase 2 · completed Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma · 244 trials list this drug (57 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05366816Phase 2 · recruiting ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06887218Phase 2 · recruiting 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05113368Phase 2 · recruiting Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer · 244 trials list this drug (57 active) | — | — | Malignant Ovarian Neoplasm,Ovarian Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07134205Phase 3 · not yet recruiting The Study of JMT101 Combined With Irinotecan as a ≥3rd-Line Treatment in Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07100392Phase 2 · recruiting Tauroursodeoxycholic Acid (TUDCA) Plus Camrelizumab and Regorafenib in Hepatocellular Carcinoma Previously Treated With Anti-PD1/PD-L1 and Bevacizumab · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874207Phase 4 · completed Evaluation of Treatment PERSOnalization Based on Its Therapeutic Monitoring in Patients With Metastatic Colorectal Cancer Treated With REgorafenib · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07078305Phase 2 · not yet recruiting Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02368886Phase 2 · completed Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm,Colon Adenocarcinoma,Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04051606Phase 2 · completed Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma · 244 trials list this drug (57 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06321055completed An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04696055Phase 2 · completed Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06949982Phase 2 · recruiting Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04704154Phase 2 · completed A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors · 244 trials list this drug (57 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02934529Phase 3 · completed Metastatic Colorectal Cancer (RAS-wildtype) After Response to First-line Treatment With FOLFIR Plus Cetuximab · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05713994recruiting Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03899428Phase 2 · recruiting Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03627728Phase 2 · completed Study Maintenance Regorafenib vs Placebo, no Progression Patients After I Line Chemotherapy Metastatic Gastric Cancer · 244 trials list this drug (57 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05770882Phase 1/Phase 2 · terminated Chidamide + Regorafenib in Hepatocellular Carcinoma (HCC) · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05057052Phase 2 · recruiting Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver Metastasis · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06029010completed An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06829355Phase 2 · recruiting "Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer" · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03406871Phase 1 · completed Regorafenib and Nivolumab Simultaneous Combination Therapy · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06425133Phase 2 · recruiting Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal Cancers · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04534218Phase 2 · completed Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Neoplasm,Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05462613Phase 2/Phase 3 · recruiting Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03563157Phase 1/Phase 2 · terminated QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03564938Phase 4 · completed Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC). · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06575725Phase 2 · withdrawn Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm,Colon Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06682611Phase 1/Phase 2 · not yet recruiting Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors. · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02096354Phase 2 · completed A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02175095NA · completed [18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04117945Phase 2 · active not recruiting Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Adenocarcinoma,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05963490Phase 2 · recruiting Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02466009Phase 2 · completed Regorafenib in Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04170556Phase 1/Phase 2 · completed Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING) · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05159245Phase 2 · recruiting The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs · 244 trials list this drug (57 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Malignant Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02581059Phase 2 · terminated Efficacy of Ginseng for Patients on Regorafenib · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05717738unknown Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04625907Phase 1/Phase 2 · recruiting FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma · 244 trials list this drug (57 active) | — | — | Rhabdomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03992456Phase 2 · unknown Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Carcinoma,Malignant Colorectal Neoplasm,Colon Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05900648Phase 2 · withdrawn Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME) · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm,Malignant Colon Neoplasm,Rectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085148Phase 1 · completed A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 244 trials list this drug (57 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06283303Phase 1 · unknown A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04810182completed Regorafenib in Patients With Relapsed Glioblastoma. IOV-GB-1-2020 REGOMA-OSS · 244 trials list this drug (57 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02925234Phase 2 · recruiting The Drug Rediscovery Protocol (DRUP Trial) · 244 trials list this drug (57 active) | — | — | Neoplasm,Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05962450Phase 2 · unknown Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06200363Phase 1 · unknown A Clinical Study of T3011 in Combination With Regorafenib in Patients With Advanced Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02316340Phase 2 · completed Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02195011Phase 2 · completed Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02795156Phase 2 · completed Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations · 244 trials list this drug (57 active) | — | — | Lung Non-Small Cell Carcinoma,Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02024607Phase 1/Phase 2 · completed A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03215264Phase 1 · completed To Determine the Safety of Regorafenib, Hydroxychloroquine, and Entinostat Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048371Phase 2 · completed SARC024: A Blanket Protocol to Study Oral Regorafenib in Patients With Selected Sarcoma Subtypes · 244 trials list this drug (57 active) | — | — | Liposarcoma,Osteosarcoma,Mesenchymal Chondrosarcoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03555149Phase 1/Phase 2 · terminated A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Metastatic Colorectal Cancer (Morpheus-CRC) · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05594147completed An Observational Study, Called ROCURS, to Learn About COVID-19 Related Outcomes in People With Cancer Who Are Treated With Tyrosine Kinase Inhibitors (TKIs) Including Regorafenib or Sorafenib · 244 trials list this drug (57 active) | — | — | Malignant Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05985109Phase 2 · recruiting KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06099821Phase 2 · recruiting KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade · 244 trials list this drug (57 active) | — | — | Malignant Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05370807Phase 2 · unknown A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma · 244 trials list this drug (57 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02383433Phase 2 · terminated Regorafenib Plus Gemcitabine in Metastatic Pancreatic Cancer · 244 trials list this drug (57 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06089330Phase 2 · unknown A Study of JMT101 in Patients With Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02584465Phase 2 · completed REGorafenib vsTamoxifen in Patients With Platinum-sensitive OVARian Carcinoma and Isolated Biological Progression · 244 trials list this drug (57 active) | — | — | Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05993702unknown TAS-102 in Combination With Regorafenib or Fruquintinib for Third-line and Above Advanced Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Digestive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03520842Phase 2 · completed Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer · 244 trials list this drug (57 active) | — | — | Brain Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05970705Phase 2 · unknown Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03347292Phase 1 · completed Regorafenib Plus Pembrolizumab in First Line Systemic Treatment of HCC · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02106858completed Stivarga Regulatory Post-Marketing Surveillance Study in Korea · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04126733Phase 2 · completed Study on the Effectiveness and Safety of the Combination of the Two Drugs Regorafenib and Nivolumab in Patients With Colorectal Cancer (Cancer of the Colon or Rectum Classified as Proficient Mismatch Repair and Microsatellite Stable) · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05818267NA · unknown Efficacy and Safety of Regorafenib Maintenance Therapy in Patients With Metastatic Colorectal Cancer (mCRC) · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02365441Phase 2 · unknown A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03289273completed Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) · 244 trials list this drug (57 active) | — | — | Liver Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05382741Phase 2 · unknown Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05794971Phase 3 · recruiting Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05134532Phase 2 · unknown Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05811481unknown Regorafenib Alone or in Combined With Transcatheter Arterial ChEmoembolization in Treatment of Advanced Hepatocellular Carcinoma After First Line Targeted Therapy · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05048017Phase 2 · unknown Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02638766Phase 2 · completed Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02619435Phase 2 · unknown Regorafenib Monotherapy as Second-line Treatment of Patients With RAS-mutant Advanced Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02910843Phase 1 · terminated Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05557656unknown A Real World Study of Regogfinib in HCC · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05644392Phase 1 · unknown A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04718909Phase 2 · unknown Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03465722Phase 3 · completed (VOYAGER) Study of Avapritinib vs Regorafenib in Patients With Locally Advanced Unresectable or Metastatic GIST · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02307500Phase 2 · completed Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy · 244 trials list this drug (57 active) | — | — | Melanoma,Sarcoma,Thymus Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02926222Phase 2 · completed Regorafenib in Relapsed Glioblastoma · 244 trials list this drug (57 active) | — | — | Glioblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985136Phase 3 · terminated A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatment of Patients With Advanced Hepatocellular Carcinoma (HCC) · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05524155Phase 2 · unknown Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05426811Phase 1/Phase 2 · unknown Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02736305Phase 2 · completed Use of Regorafenib in Recurrent Epithelial Ovarian Cancer · 244 trials list this drug (57 active) | — | — | Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04200404Phase 1/Phase 2 · completed A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid Tumors · 244 trials list this drug (57 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02048722Phase 2 · completed Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma · 244 trials list this drug (57 active) | — | — | Adult Soft Tissue Sarcoma,Adult Angiosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02080260Phase 2 · completed A Study of Regorafenib in Advanced Pancreatic Cancer Patients · 244 trials list this drug (57 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02664077Phase 3 · terminated A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer · 244 trials list this drug (57 active) | — | — | Colon Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01933958completed Regorafenib Post-marketing Surveillance in Japan · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03475251Phase 1 · completed A Study of CS1003 in Subjects With Advanced Solid Tumors · 244 trials list this drug (57 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05233358NA · unknown HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03099486Phase 2 · terminated Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02773524Phase 3 · unknown A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04476329Phase 2 · terminated Optimization for Regorafenib in HCC · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259725Phase 2 · completed Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors · 244 trials list this drug (57 active) | — | — | Digestive System Neuroendocrine Tumor G1,Gastrin-Producing Neuroendocrine Tumor,Lung Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05130021Phase 2 · unknown A Clincal Study of Max-40279-01 in Patients With Advanced Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02115542Phase 2 · completed Single Agent Regorafenib in Refractory Advanced Biliary Cancers · 244 trials list this drug (57 active) | — | — | Malignant Bile Duct Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05025592unknown cTACE or DEB-TACE+HAIC Combined With Regorafenib ± Anti-PD1 Antibody for uHCC · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03829852completed Regorafenib in Taiwan Metastatic Colorectal Cancer (mCRC) Patients · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02439723Phase 1 · withdrawn Effects of LBM and PPIs on Pharmacokinetics and Safety of Regorafenib (BAY 73-4506) in Cancer Patients · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02164240Phase 1 · completed Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03010722completed Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02501551Phase 2 · unknown Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy · 244 trials list this drug (57 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02095054Phase 1 · completed Regorafenib and Cetuximab in Patients With Advanced Malignancy · 244 trials list this drug (57 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03305913Phase 1 · completed Regorafenib in Combination With TAS-102 in Subjects With Metastatic Colorectal Cancer Who Have Progressed After Standard Therapy · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04771715unknown Regorafenib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Patients With Advanced Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00664326Phase 2 · completed A Phase II Uncontrolled Study of BAY73-4506 in Previously Untreated Patients With Metastatic or Unresectable RCC · 244 trials list this drug (57 active) | — | — | Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01271712Phase 3 · completed Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST) · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01298570Phase 2 · completed Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03081494Phase 1 · completed Phase Ib Study of PDR001 in Combination With Regorafenib in Adult Patients With Previously Treated Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01896856Phase 1/Phase 2 · completed Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01068769Phase 2 · completed Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03644511terminated Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01774344Phase 3 · completed Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma · 244 trials list this drug (57 active) | — | — | Hepatocellular Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02459119Phase 2 · completed Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477) · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04431791unknown Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01913639Phase 2 · completed FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer · 244 trials list this drug (57 active) | — | — | Malignant Esophageal Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03946917Phase 1/Phase 2 · unknown JS001 Combined With Regorafenib in Patients With Advanced Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02835924Phase 2 · completed Study Comparing Different Dose Approaches of Induction Treatment of Regorafenib in MCRC · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02466802Phase 1 · completed Study of Regorafenib and Sildenafil for Advanced Solid Tumors · 244 trials list this drug (57 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02425683Phase 2 · terminated Study of Colorectal Cancer Patients (Stage IIIC) With Either Regorafenib or Standard of Care (No Treatment) After Adjuvant FOLFOX · 244 trials list this drug (57 active) | — | — | Colorectal Neoplasm,Colon Adenocarcinoma,Rectal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02587650Phase 2 · terminated Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma · 244 trials list this drug (57 active) | — | — | Cutaneous Melanoma,Invasive Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02889328Phase 2 · completed Phase II Study of Regorafenib Continuous Dosing of Regorafenib in Patients With GISTs · 244 trials list this drug (57 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02788279Phase 3 · completed A Study to Investigate Efficacy and Safety of Cobimetinib Plus Atezolizumab and Atezolizumab Monotherapy Versus Regorafenib in Participants With Metastatic Colorectal Adenocarcinoma (COTEZO IMblaze370) · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02406170Phase 1/Phase 2 · completed Regorafenib in Combination With Paclitaxel in Advanced Oesophagogastric Carcinoma · 244 trials list this drug (57 active) | — | — | Esophageal Neoplasm,Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02651415Phase 2 · completed Phase II Study of Perindopril and Regorafenib in mCRC · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01287598Phase 1 · completed BAY73-4506 Probe Substrate Study · 244 trials list this drug (57 active) | — | — | Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04008511Phase 1/Phase 2 · unknown Regorafenib and XELOX as 2nd Line Treatment in Metastatic Colorectal Cancer · 244 trials list this drug (57 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01929616Phase 2 · completed Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C) · 244 trials list this drug (57 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |